Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
-
Europe scorched by latest heatwave
-
UK's Starmer resigns as prime minister
-
Coffee break: Starbucks Korea stores pause for training after 'Tank Day' fiasco
-
Rightist leaders congratulate Colombian president-elect
-
Rare Philippine school shooting kills three teens, wounds seven
-
Kenya labour minister accused over Russian forced recruitment
-
Crude prices drop after 'positive' US-Iran talks
-
Some France schools closed for day of searing heat
-
Tuchel's England face defensive questions despite flying start at World Cup
-
Frankfurt to All Blacks: New Zealand pick first German-born player
-
Not just a hideout: Sahel forests provide base for jihadists
-
Ageless Messi has World Cup scoring record in his sights
-
Africa faces child surgery crisis as key anaesthesia runs out
-
Trump-backed populist wins razor-tight Colombia vote, sparking protests
-
J-Bay: S.Africa's surf mecca missing out on the global tour
-
'Progress', say mediators, after Iran-US talks towards ending war
-
Key points from the first round of Iran-US talks
-
European countries close schools, cancel trains as heatwave set to intensify
-
Crude prices drop, most stocks rise on 'positive' US-Iran talks
-
Slimy beans: Japanese natto disgusts and delights the world
-
Clark wins despite hecklers but hopes not to be 'heel of the PGA'
-
Cape Verde targeting World Cup knockout rounds after Uruguay draw: coach
-
Father's Day near-miss at US Open brings Burns to tears
-
New coach Rennie names Savea as All Blacks captain
-
Scheffler praises Clark's resolve in gutsy US Open triumph
-
Yamal kickstarts Spain World Cup bid as Cape Verde stun Uruguay
-
Cape Verde fight back for second World Cup draw against Uruguay
-
American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
-
Apex Drills 14.9 m of 5.09 % REO and 12.3 m of 5.63 % REO with > 2.50 % REO Intercept Over 191.9 m in the Trinity Zone at the Rift Rare Earth Project
-
Bear Robotics to Acquire Kinisi Robotics, Completing Its End-to-End Physical AI Robotics Platform
-
Introduces POS Ready for FWA12 to Help Retailers and Restaurants Protect Payment Traffic
-
Empire Metals Limited Announces Massive High-Grade Core Confirmed at Thomas
-
Guardian Metal Resources PLC Announces Holding(s) in Company
-
Genflow Biosciences PLC Announces Participation at BIO International Convention 2026
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 22
-
Best Gold IRA Companies for a 401(k) Rollover in 2026: Expert Rankings Released
-
Mexican fans rally behind Iran as 'our second team' at World Cup
-
Trump-backed candidate wins razor-tight Colombia presidential election
-
Clark edges Burns by one stroke for second US Open title
-
Iran coach hails 'great achievement' after second World Cup draw
-
Curacao firmly on the map after World Cup heroics
-
Pro-Trump presidential hopeful takes early lead as Colombia counts votes
-
Trump say repairs to begin 'immediately' for Washington pool renovation
-
Yamal off the mark at World Cup in Spain rout as Iran hold Belgium
-
Rune 'not ready' to put a date on tennis return
-
Argentina weaknesses? Austria's World Cup coach can't find any
-
Polls close in Colombia runoff pitting pro-Trump hardliner against leftist
-
A nation divided over Team Melli as Iran faces Belgium
-
McIlroy races for exit after weekend US Open fade
-
Belgium held 0-0 by Iran as Ngoy sent off
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.
Company Webcast
The webcast presentation will take place at 9:15 a.m. Eastern time on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/8p9EoXv752z. The webcast will also be available for replay following the event. It will also be accessible on the Investors section of the Company's website at https://investors.aytubio.com/ under Events & Presentations.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at [email protected] or register for the event at https://lythampartners.com/spring2026invreg/.
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), and treatments for attention deficit-hyperactivity disorder (ADHD). Aytu is committed to delivering the Company's medications through best-in-class patient access programs that help to enable optimal patient outcomes. For more information, please visit aytubio.com or follow us on LinkedIn.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
S.F.Warren--AMWN